These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 34319562)
1. Hypersensitivity and Immune-related Adverse Events in Biologic Therapy. Waldron JL; Schworer SA; Kwan M Clin Rev Allergy Immunol; 2022 Jun; 62(3):413-431. PubMed ID: 34319562 [TBL] [Abstract][Full Text] [Related]
2. Immunologic Adverse Effects of Biologics for the Treatment of Atopy. Aranez V; Ambrus J Clin Rev Allergy Immunol; 2020 Oct; 59(2):220-230. PubMed ID: 31301006 [TBL] [Abstract][Full Text] [Related]
3. Are biologics safe in the treatment of atopic dermatitis? A review with a focus on immediate hypersensitivity reactions. Bremmer MS; Bremmer SF; Baig-Lewis S; Simpson EL J Am Acad Dermatol; 2009 Oct; 61(4):666-76. PubMed ID: 19646779 [TBL] [Abstract][Full Text] [Related]
4. Adverse Reactions to Biologic Therapy. Patel SV; Khan DA Immunol Allergy Clin North Am; 2017 May; 37(2):397-412. PubMed ID: 28366484 [TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Khan DA Ann Allergy Asthma Immunol; 2016 Aug; 117(2):115-20. PubMed ID: 27499538 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of adverse drug reactions to biologics. Clarke JB Handb Exp Pharmacol; 2010; (196):453-74. PubMed ID: 20020272 [TBL] [Abstract][Full Text] [Related]
10. Severe Immediate and Delayed Hypersensitivity Reactions to Biologics in a Toddler With Systemic Juvenile Idiopathic Arthritis. Villacis-Nunez DS; Bilcha K; Spraker M; Rouster-Stevens K; Cooley A J Investig Med High Impact Case Rep; 2022; 10():23247096221077836. PubMed ID: 35225032 [TBL] [Abstract][Full Text] [Related]
11. Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies. Cannon L; Pan A; Kovalick L; Sarkissian A; Wu EY Ann Allergy Asthma Immunol; 2023 Jun; 130(6):718-726. PubMed ID: 36801438 [TBL] [Abstract][Full Text] [Related]
12. Smallpox vaccination and adverse reactions. Guidance for clinicians. Cono J; Casey CG; Bell DM; MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions to biologics. Scherer K; Spoerl D; Bircher AJ J Dtsch Dermatol Ges; 2010 Jun; 8(6):411-26. PubMed ID: 20136676 [TBL] [Abstract][Full Text] [Related]
15. Establishing clinical guidelines for the management of acute hypersensitivity reactions secondary to the administration of chemotherapy/biologic therapy. Timoney JP; Eagan MM; Sklarin NT J Nurs Care Qual; 2003; 18(1):80-6. PubMed ID: 12518842 [TBL] [Abstract][Full Text] [Related]
17. Management of adverse reactions to biologic agents. Isabwe GAC; de Las Vecillas Sanchez L; Castells M Allergy Asthma Proc; 2017 Nov; 38(6):409-418. PubMed ID: 29046192 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders. Garcovich S; De Simone C; Genovese G; Berti E; Cugno M; Marzano AV Front Pharmacol; 2019; 10():282. PubMed ID: 30971924 [TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity and adverse reactions to biologics for asthma and allergic diseases. Jackson K; Bahna SL Expert Rev Clin Immunol; 2020 Mar; 16(3):311-319. PubMed ID: 31994421 [No Abstract] [Full Text] [Related]
20. Rituximab Hypersensitivity: From Clinical Presentation to Management. Fouda GE; Bavbek S Front Pharmacol; 2020; 11():572863. PubMed ID: 33013416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]